English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 13 Help

Selected(0)Clear Items/Page:    Sort:
A Qualitative Cost-Benefit Analysis of the Maritime Silk Road in Europe: Who Benefits from the Initiative and Who Does Not Journal article
Galan, Enrique, Leandro, Francisco. A Qualitative Cost-Benefit Analysis of the Maritime Silk Road in Europe: Who Benefits from the Initiative and Who Does Not[J]. Asian Perspective, 2024, 48, 13-39.
Authors:  Galan, Enrique;  Leandro, Francisco
Adobe PDF | Favorite | TC[WOS]:0 TC[Scopus]:0  IF:1.3/1.1 | Submit date：2024/02/27
China  21st Century Maritime Silk Road  Maritime Trade  Cost-benefit Analysis  Connectivity  Realism  Analytic Hierarchy Process  
Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China Journal article
Liu, Lei, Ruan, Zhen, Ung, Carolina Oi Lam, Zhang, Yawen, Shen, Yang, Han, Sheng, Jia, Ruxu, Qiao, Jingtao, Hu, Hao, Guo, Lixin. Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China[J]. Diabetes Therapy, 2023, 14(1), 93-107.
Authors:  Liu, Lei;  Ruan, Zhen;  Ung, Carolina Oi Lam;  Zhang, Yawen;  Shen, Yang; et al.
Favorite | TC[WOS]:6 TC[Scopus]:8  IF:2.8/2.9 | Submit date：2023/01/08
Cost-effectiveness Analysis  Type 2 Diabetes  Glucagon-like Peptide-1 Analogue  Semaglutide  Peg-loxenatide  China  
The cost-effectiveness analysis of analgesic treatment options for postoperative pain following laparotomy surgeries Journal article
Xie, Han, Chen, Si Huang, Li, Li, Ge, Wei Hong. The cost-effectiveness analysis of analgesic treatment options for postoperative pain following laparotomy surgeries[J]. International Journal of Clinical Pharmacy, 2022.
Authors:  Xie, Han;  Chen, Si Huang;  Li, Li;  Ge, Wei Hong
Favorite | TC[WOS]:2 TC[Scopus]:3  IF:2.6/2.4 | Submit date：2023/01/30
Cost-effectiveness Analysis  Dezocine  Flurbiprofen  Patient-controlled Analgesia  Postoperative Pain  
Efficacy, safety, and cost-effectiveness analysis of aflibercept in metastatic colorectal cancer: A rapid health technology assessment Review article
2022
Authors:  Ge, Pu;  Wan, Ning;  Han, Xiao;  Wang, Xinpei;  Zhang, Jinzi; et al.
Favorite | TC[WOS]:2 TC[Scopus]:1  IF:4.4/5.0 | Submit date：2023/01/30
Aflibercept  Cost-effectiveness Analysis  Metastatic Colorectal Cancer  Pharmacoeconomics  Rapid Health Technology Assessment  Targeted Drugs  
Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review Journal article
Zejun Luo, Zhen Ruan, Dongning Yao, Carolina Oi Lam Ung, Yunfeng Lai, Hao Hu. Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review[J]. Frontiers in Public Health, 2021, 9.
Authors:  Zejun Luo;  Zhen Ruan;  Dongning Yao;  Carolina Oi Lam Ung;  Yunfeng Lai; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:3.0/3.6 | Submit date：2022/05/13
Budget Impact Analysis  Diabetes  Cost-effectiveness  Bia  Cea  
China county based COPD screening and cost-effectiveness analysis Journal article
Du, Minghua, Hu, Hao, Zhang, Lei, Liu, Wenpeng, Chu, Tianbao, Wu, Guoxia, Wang, Xiaoling, Li, Ling, Wang, Jing, Zheng, Lingling, Bai, Shuchen. China county based COPD screening and cost-effectiveness analysis[J]. Annals of palliative medicine, 2021, 10(4), 4652-4660.
Authors:  Du, Minghua;  Hu, Hao;  Zhang, Lei;  Liu, Wenpeng;  Chu, Tianbao; et al.
Favorite | TC[WOS]:6 TC[Scopus]:7  IF:1.925/2.051 | Submit date：2021/12/07
China County  Chronic Obstructive Pulmonary Disease (Copd)  Cost-effectiveness Analysis  Questionnaire Screening  
The cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review Review article
2021
Authors:  Zhen Ruan;  Lisong Yang;  Honghao Shi;  Xiaomeng Yue;  Yao Wang; et al.
Favorite | TC[WOS]:11 TC[Scopus]:13  IF:1.8/2.2 | Submit date：2021/03/01
Cost-effectiveness Analysis  Diabetes  Once-weekly Semaglutide  Review  
Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease Journal article
Dong P., Hu H., Guan X., Ung C.O.L., Shi L., Han S., Yu S.. Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease[J]. Chinese Medicine, 2018, 13(1).
Authors:  Dong P.;  Hu H.;  Guan X.;  Ung C.O.L.;  Shi L.; et al.
Favorite | TC[WOS]:11 TC[Scopus]:14 | Submit date：2018/11/06
Chronic Ischemic Heart Disease  Coronary Heart Disease  Cost-consequence Analysis  Pharmacoeconomics  Salvianolate Injection  Traditional Chinese Medicine  
Cost‑consequence analysis of salvianolate injection for the treatment of coronary heart disease Journal article
Dong, P. G., Hu, H., Guan, X. D., Ung, O. L. C., Shi, L. W., Han, S., Yu, S. W.. Cost‑consequence analysis of salvianolate injection for the treatment of coronary heart disease[J]. Chinese Medicine, 2018, 1-9.
Authors:  Dong, P. G.;  Hu, H.;  Guan, X. D.;  Ung, O. L. C.;  Shi, L. W.; et al.
Favorite | TC[WOS]:11 TC[Scopus]:14  IF:5.3/5.5 | Submit date：2022/07/27
Cost-consequence Analysis  Salvianolate Injection  Coronary Heart Disease  Chronic Ischemic Heart  
Issues with China’s On-going GPA Accession: Costs, Benefits and Challenges of Accession and Implementation Journal article
Wang, C.. Issues with China’s On-going GPA Accession: Costs, Benefits and Challenges of Accession and Implementation[J]. Journal of International and Comparative Law, 2015, 259-273.
Authors:  Wang, C.
Favorite |   IF:0.4/0 | Submit date：2022/08/30
China  Wto  Gpa  Implementation  Cost-benefit Analysis